ACCESSION: MSBNK-SMB_Measured-HSA001P0199027
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 18
COMMENT: RAW_SPEC {'1_posi_15444': {'bp': 140246.0, 'sum': 800177.0}, '4_posi_15423': {'bp': 108029.0, 'sum': 670363.0}, '6_posi_15422': {'bp': 121021.0, 'sum': 741219.0}, '5_posi_15364': {'bp': 113475.0, 'sum': 673238.0}, '15_posi_15403': {'bp': 124477.0, 'sum': 697456.0}, '17_posi_15444': {'bp': 123090.0, 'sum': 723654.0}, '11_posi_15425': {'bp': 135337.0, 'sum': 816588.0}, '9_posi_15425': {'bp': 119225.0, 'sum': 754540.0}, '8_posi_15402': {'bp': 121181.0, 'sum': 698066.0}, '2_posi_15446': {'bp': 137576.0, 'sum': 819917.0}, 'BLK02_15423': {'bp': 127593.0, 'sum': 764468.0}, 'BLK01_15380': {'bp': 127345.0, 'sum': 834238.0}, '12_posi_15403': {'bp': 111309.0, 'sum': 638846.0}, '3_posi_15384': {'bp': 119431.0, 'sum': 707105.0}, '13_posi_15424': {'bp': 133070.0, 'sum': 784935.0}, '19_posi_15426': {'bp': 112997.0, 'sum': 651680.0}, '10_posi_15381': {'bp': 111858.0, 'sum': 665069.0}, '4_posi_15362': {'bp': 108670.0, 'sum': 653730.0}}
COMMENT: RETENTION_TIME_STDEV 0.059
COMMENT: PRECURSOR_M/Z_RAW 199.154989
COMMENT: PRECURSOR_M/Z_STDEV 0.000062
COMMENT: PRECURSOR_IN_MS1 mz 199.155315; int 45.976; delta(ppm) 0.966755
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 240.181727; int 19.549; cor 0.649
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 240.181727; int 19.549; cor 0.649
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 240.181727; int 19.549; cor 0.649
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.106; C9H18N4O; [M+H]+; delta(ppm) -0.105981
COMMENT: PROPOSED_MF SevenGoldenRules 0.121; C7H15N3O; [M+ACN+H]+; delta(ppm) -0.120926
COMMENT: PROPOSED_MF MS-FINDER 3.370; C9H18N4O; [M+H]+; delta(ppm) -0.108748
COMMENT: PROPOSED_MF MS-FINDER 3.093; C7H15N3O; [M+ACN+H]+; delta(ppm) 81590.731930
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.252; C7H15N3O; [M+C2H3N+H]+; delta(ppm) -0.108748
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.252; C9H18N4O; [M+H]+; delta(ppm) -0.108748
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H15N3O; [M+C2H3N+H]+; delta(ppm) -0.108748
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H18N4O; [M+H]+; delta(ppm) -0.108748
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.292; C7H15N3O; [M+C2H3N+H]+; delta(ppm) -0.108748
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.292; C9H18N4O; [M+H]+; delta(ppm) -0.108748
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.482; C9H22NO2; [M+Na]+; delta(ppm) 47262.191955
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.747; C9H17O2; [M+C2H3N+H]+; delta(ppm) -6.850492
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.747; C11H20NO2; [M+H]+; delta(ppm) -6.850492
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.770; C5H13N6; [M+C2H3N+H]+; delta(ppm) 6.633088
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.770; C7H16N7; [M+H]+; delta(ppm) 6.633088
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H15N3O; [M+C2H3N+H]+; delta(ppm) -0.108748
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H22NO2; [M+Na]+; delta(ppm) 47262.191955
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H18N4O; [M+H]+; delta(ppm) -0.108748
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.555; YLJXZSWHZFXCDY-JHPDDGAFNA-N; [M+H]+; Amidinomycin;Amidinomycine;HU 1/68;Myxoviromycin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.395; NKNWKZRTEZPNSM-UHFFFAOYSA-N; [M+ACN+H]+; [(2-ethylbutylidene)amino]urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; YLJXZSWHZFXCDY-JHPDDGAFNA-N; [M+H]+; Amidinomycin;Amidinomycine;HU 1/68;Myxoviromycin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NKNWKZRTEZPNSM-UHFFFAOYSA-N; [M+ACN+H]+; [(2-ethylbutylidene)amino]urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.901; YLJXZSWHZFXCDY-RQJHMYQMSA-N; [M+H]+; (1R,3S)-3-amino-N-(3-amino-3-iminopropyl)cyclopentane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.262; XMFYMWXCIWIHAC-UHFFFAOYSA-N; [M+ACN+H]+; N,N-dimethylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.550; FWHRLKTXFMRLDV-UHFFFAOYSA-N; [M+ACN+H]+; 4-(methylamino)piperidine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.500; FWFVZEXRAAFFEU-UHFFFAOYSA-N; [M+ACN+H]+; N'-hydroxy-2-piperidin-1-ylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.379; VRZZMRYGHFNKEN-UHFFFAOYSA-N; [M+ACN+H]+; 2-(4-methylpiperazin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.295; SOTHHBNFPDRYCM-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-2-piperazin-1-ylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.125; PQJWLDHHBMBKDM-JTHIGBGISA-N; [M+ACN+H]+; (2E)-2-hydroxyimino-N,N-dimethyl-N'-propylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.093; HQXKCSSNQJUVML-UHFFFAOYSA-N; [M+ACN+H]+; 1-(3-aminopropyl)-1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.010; OOZJHQLYZLXPIF-UHFFFAOYSA-N; [M+H]+; 3-(azidomethyl)-1-hydroxy-2,2,5,5-tetramethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.991; DIDCDJTVKPODTM-UHFFFAOYSA-N; [M+ACN+H]+; N-ethylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.947; VVWMANLRLRFZIZ-UHFFFAOYSA-N; [M+ACN+H]+; 3-piperazin-1-ylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.892; WKRXPJVFLDWSFL-UHFFFAOYSA-N; [M+ACN+H]+; 4-ethylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.883; PBEHKSXYRLKENN-UHFFFAOYSA-N; [M+ACN+H]+; 1-[3-(methylamino)propyl]imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.873; DXLMAWKTIWMTIM-UHFFFAOYSA-N; [M+ACN+H]+; 2-piperazin-1-ylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.870; VEEWCGJMSJUBTC-UHFFFAOYSA-N; [M+ACN+H]+; N'-hydroxy-1-methylpiperidine-4-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.868; ASTGCFFFALEDKG-UHFFFAOYSA-N; [M+ACN+H]+; N'-hydroxy-1-methylpiperidine-3-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.806; JWRVCVWALQWYIJ-UHFFFAOYSA-N; [M+ACN+H]+; 2-(4-aminopiperidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.789; NGWNLUZOEYRHAX-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-piperidin-4-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.775; UJCRXTPCKWHFIK-LURJTMIESA-N; [M+ACN+H]+; (3S)-3-amino-N-ethylpyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.773; VZVGVHNZWUQMRZ-UHFFFAOYSA-N; [M+ACN+H]+; 1-amino-3-cyclohexylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.750; TUDVAMWISALGGV-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1,4-diazepan-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.749; DTZYYZWYSRPUGM-UHFFFAOYSA-N; [M+ACN+H]+; piperidin-4-ylmethylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.739; SCLKLJIOJCJNNM-UHFFFAOYSA-N; [M+ACN+H]+; 4-amino-N-methylpiperidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.734; RPOOCEPQRXHAMR-UHFFFAOYSA-N; [M+ACN+H]+; (1-ethylpyrrolidin-3-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.732; YXJSNYWHCBOJHS-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-aminopiperidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.731; YRKJGBJXQSEVRL-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-(pyrrolidin-2-ylmethyl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.729; HOXAJWHRILSLKM-UHFFFAOYSA-N; [M+ACN+H]+; (4-methylpentan-2-ylideneamino)urea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.726; FDPBEKRDJYDLHO-UHFFFAOYSA-N; [M+ACN+H]+; azepan-4-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.339; ANHJTNKMQWWMDJ-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-1-(4-methylpiperazin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.330; MVWYSRAIAUAMJL-UHFFFAOYSA-N; [M+ACN+H]+; N,N-dimethylpiperazine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.308; KIPRVSOTALWIDV-UHFFFAOYSA-N; [M+ACN+H]+; 3-amino-1-piperazin-1-ylpropan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.286; WAKDYASVWVWGLD-UHFFFAOYSA-N; [M+ACN+H]+; 3-amino-N,N-dimethylpyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.270; WXEPBEURAILKFS-UHFFFAOYSA-N; [M+ACN+H]+; 4-(2-aminoethyl)-1-methylpiperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.145; OUKAZIMLLPOLKQ-UHFFFAOYSA-N; [M+ACN+H]+; 4-methoxypiperidine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.104; DGBWASUSQBEAOY-UHFFFAOYSA-N; [M+ACN+H]+; 2-methyl-1-(oxolan-3-ylmethyl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.067; PSTIPACOMKTMDU-UHFFFAOYSA-N; [M+ACN+H]+; 3-methyl-5-pyrrolidin-3-yl-1,2,4-oxadiazolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.813; ANHJTNKMQWWMDJ; [M+C2H3N+H]+; 2-amino-1-(4-methylpiperazin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.646; XMFYMWXCIWIHAC; [M+C2H3N+H]+; 1-(Dimethylcarbamoyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.949; RPOOCEPQRXHAMR; [M+C2H3N+H]+; (1-Ethyl-3-pyrrolidinyl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.184; KIPRVSOTALWIDV; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -230.622; MPIROZKBCRIFBH; [M+C2H3N+H]+; 1,2,6-Trimethyl-4-nitrosopiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -230.892; LWDYSDHYADWNAS; [M+C2H3N+H]+; AP-1,3-Dazaha
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.802; FWHRLKTXFMRLDV; [M+C2H3N+H]+; 4-(Methylamino)piperidine-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -261.073; DSLSNSBQZMOQQK; [M+C2H3N+H]+; N-Amidinohexanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -274.359; KNVTVOWFXJOWKI; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -281.645; HOXAJWHRILSLKM; [M+C2H3N+H]+; 4-methyl-2-pentanone semicarbazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -365.898; YLJXZSWHZFXCDY; [M+H]+; Amidinomycin
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.092; ANHJTNKMQWWMDJ; [M+C2H3N+H]+; 2-amino-1-(4-methylpiperazin-1-yl)ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.041; YLJXZSWHZFXCDY; [M+H]+; Amidinomycin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.854; XMFYMWXCIWIHAC; [M+C2H3N+H]+; [Hydroxy(piperazin-1-yl)methylidene]-dimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -132.926; FJCINUAQJFDNTC; [M+H]+; 1-[3-[(Dimethylamino)methyl]-1,2,4-oxadiazol-5-yl]-2-methylpropan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -134.302; YINMCCATZKNNTB; [M+H]+; N',N'-dimethyl-N-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]propane-1,3-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -135.875; MNYOSFOLMMFTIC; [M+H]+; 3-[3-[(dimethylamino)methyl]-1,2,4-oxadiazol-5-yl]-N-methylpropan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -136.803; XLZQVTIJYSXGDN; [M+H]+; 2-[3-[(Dimethylamino)methyl]-1,2,4-oxadiazol-5-yl]butan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -137.147; RFYSYWDPQYEFGB; [M+H]+; N'-methyl-N'-[(5-propan-2-yl-1,2,4-oxadiazol-3-yl)methyl]ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -137.523; QQWHJRVPMMZROE; [M+H]+; N-[[1-(3-methoxypropyl)triazol-4-yl]methyl]ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -139.211; GNSUAMNUWCSLPO; [M+H]+; 2-{3-[(Diethylamino)methyl]-1,2,4-oxadiazol-5-yl}ethan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -139.381; AZYIJXNDWIGCNW; [M+H]+; 2-[5-[[Ethyl(methyl)amino]methyl]-1,2,4-oxadiazol-3-yl]propan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -139.809; BTPBKNJGDJJTTN; [M+H]+; N',N'-dimethyl-N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]propane-1,3-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -141.314; KGJQPKCQCPNVEL; [M+H]+; N'-methyl-N'-[(3-propan-2-yl-1,2,4-oxadiazol-5-yl)methyl]ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -142.027; PQJWLDHHBMBKDM; [M+C2H3N+H]+; 2-hydroxyimino-N,N-dimethyl-N'-propylethanimidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -147.897; HQXKCSSNQJUVML; [M+C2H3N+H]+; 1-(3-Aminopropyl)tetrahydro-2(1h)-pyrimidinone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -174.285; VRZZMRYGHFNKEN; [M+C2H3N+H]+; 2-(4-Methylpiperazin-1-YL)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -181.411; NKNWKZRTEZPNSM; [M+C2H3N+H]+; [(2-ethylbutylidene)amino]urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -183.024; ANHJTNKMQWWMDJ; [M+C2H3N+H]+; 2-Amino-1-(4-methyl-piperazin-1-yl)-ethanone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -186.963; KNVTVOWFXJOWKI; [M+C2H3N+H]+; 1-(3-Methylbutyl)triazolidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -187.834; MPIROZKBCRIFBH; [M+C2H3N+H]+; Piperazine, 1,2,6-trimethyl-4-nitroso-, cis-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -192.448; HOXAJWHRILSLKM; [M+C2H3N+H]+; 1-(4-Methyl-2-pentylidene)semicarbazide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -196.179; LVYPORRPEOHRHZ; [M+C2H3N+H]+; 1-Methyl-7-oxido-2,3,3a,4,5,6,7,7a-octahydropyrazolo[3,4-b]pyridin-7-ium
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.220; XMFYMWXCIWIHAC; [M+C2H3N+H]+; [Hydroxy(piperazin-1-yl)methylidene]-dimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.046; FJCINUAQJFDNTC; [M+H]+; 1-[3-[(Dimethylamino)methyl]-1,2,4-oxadiazol-5-yl]-2-methylpropan-2-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C9H19N4O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 30.942
MS$FOCUSED_ION: PRECURSOR_M/Z 199.155316
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-01ot-2900000000-08978f5ce4bfd22d550d
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0698918 455.8821 69.070517 0.4199 48.51 0.4241 18 f{C5H9}/0.22ppm,p-C4H10N4O1
  72.0443646 47.3639 72.044971 1.8461 11.71 0.5170 18 f{C3H6N1O1}/-0.36ppm,p-C6H13N3
  74.0964276 682.2871 74.097019 0.3104 54.96 0.6883 18 f{C4H12N1}/0.02ppm,p-C5H7N3O1
  86.0600411 74.6387 86.060508 1.4060 16.36 0.4056 18 f{C4H8N1O1}/0.01ppm,p-C5H11N3
  87.0916446 43.7509 87.092098 1.6305 10.21 -0.0220 13 f{C4H11N2}/-0.35ppm,p-C5H8N2O1
  100.0757017 223.5198 100.076023 0.8693 33.97 0.5067 18 f{C5H10N1O1}/0.11ppm,p-C4H9N3
  111.0917572 133.0861 111.091973 1.8183 24.35 0.4716 18 f{C6H11N2}/0.74ppm,p-C3H8N2O1
  111.1168564 935.8697 111.117072 0.3060 68.07 0.3932 18 f{C8H15}/0.27ppm,p-C1H4N4O1
  114.1026288 106.8707 114.102811 1.1919 20.83 0.5046 18 f{C5H12N3}/0.48ppm,p-C4H7N1O1
  115.0866435 113.5884 115.086814 1.0688 19.90 0.3684 18 f{C5H11N2O1}/0.47ppm,p-C4H8N2
  127.1105056 61.6772 127.110518 2.1556 6.39 0.8535 18 f{C6H13N3}/0.84ppm,p-C3H6N1O1
  154.0977448 59.7120 154.097640 2.2648 21.20 0.6223 18 f{C7H12N3O1}/1.66ppm,p-C2H7N1
  158.1539885 185.1522 158.153881 1.6882 34.27 0.1641 18 ?
  181.1447988 520.7542 181.144677 0.8281 43.33 0.6202 18 f{C9H17N4}/0.14ppm,p-H2O1
  199.1556156 984.4883 199.155482 0.5825 66.30 1.0000 18 f{C9H19N4O1}/1.40ppm,p
  199.1809090 999.0000 199.180776 0.5673 58.94 0.6223 18 ?
PK$NUM_PEAK: 16
PK$PEAK: m/z int. rel.int.
  69.069892 455.88 455
  72.044365 47.36 47
  74.096428 682.29 682
  86.060041 74.64 74
  87.091645 43.75 43
  100.075702 223.52 223
  111.091757 133.09 133
  111.116856 935.87 935
  114.102629 106.87 106
  115.086644 113.59 113
  127.110506 61.68 61
  154.097745 59.71 59
  158.153989 185.15 185
  181.144799 520.75 520
  199.155616 984.49 984
  199.180909 999.00 999
//
